Spd Vaccines And Speciality Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-06-2024
- Paid Up Capital ₹ 0.10 M
as on 26-06-2024
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Net Worth 1.50%
(FY 2022)
- Total Assets 538.60%
(FY 2022)
About Spd Vaccines And Speciality Drugs
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Krishna Gudala and Sampath Gudala serve as directors at the Company.
- CIN/LLPIN
U51909TG2020PTC139660
- Company No.
139660
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Spd Vaccines And Speciality Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Gudala  | Director | 04-Mar-2020 | Current |
| Sampath Gudala | Director | 04-Mar-2020 | Current |
Financial Performance of Spd Vaccines And Speciality Drugs.
Spd Vaccines And Speciality Drugs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 1.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Spd Vaccines And Speciality Drugs?
Unlock access to Spd Vaccines And Speciality Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sai Pharma Distributors Private LimitedActive 24 years 8 monthsKrishna Gudala and Sampath Gudala are mutual person
- Glivita Pharma Private LimitedActive 6 years 11 months
Krishna Gudala and Sampath Gudala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spd Vaccines And Speciality Drugs?
Unlock and access historical data on people associated with Spd Vaccines And Speciality Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spd Vaccines And Speciality Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spd Vaccines And Speciality Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
